177 related articles for article (PubMed ID: 29099437)
1. Isotretinoin-induced Angle Closure and Myopic Shift.
Park YM; Lee TE
J Glaucoma; 2017 Nov; 26(11):e252-e254. PubMed ID: 29099437
[TBL] [Abstract][Full Text] [Related]
2. Uveal effusion as a mechanism of bilateral angle-closure glaucoma induced by chlorthalidone.
Singer JR; Pearce ZD; Westhouse SJ; Siebert KJ
J Glaucoma; 2015 Jan; 24(1):84-6. PubMed ID: 24448565
[TBL] [Abstract][Full Text] [Related]
3. Bilateral angle closure following use of a weight loss combination agent containing topiramate.
Grewal DS; Goldstein DA; Khatana AK; Tanna AP
J Glaucoma; 2015; 24(5):e132-6. PubMed ID: 25304279
[TBL] [Abstract][Full Text] [Related]
4. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
Sakai H; Shinjyo S; Nakamura Y; Nakamura Y; Ishikawa S; Sawaguchi S
J Ocul Pharmacol Ther; 2005 Dec; 21(6):483-9. PubMed ID: 16386090
[TBL] [Abstract][Full Text] [Related]
5. Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: a case report.
Boonyaleephan S
J Med Assoc Thai; 2008 Dec; 91(12):1904-7. PubMed ID: 19133528
[TBL] [Abstract][Full Text] [Related]
6. Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion.
Kang YK; Son BJ; Park DH; Shin JP
BMC Ophthalmol; 2019 Nov; 19(1):213. PubMed ID: 31684898
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir (Tamiflu)-induced bilateral acute angle closure glaucoma and transient myopia.
Lee JW; Lee JE; Choi HY; Lee JS
Indian J Ophthalmol; 2014 Dec; 62(12):1165-7. PubMed ID: 23571265
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
Plummer CE; MacKay EO; Gelatt KN
Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
[TBL] [Abstract][Full Text] [Related]
10. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
11. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
[TBL] [Abstract][Full Text] [Related]
12. Elevated intraocular pressure and myopic shift linked to topiramate use.
Guier CP
Optom Vis Sci; 2007 Dec; 84(12):1070-3. PubMed ID: 18091300
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.
Oztürk F; Ermiş SS; Inan UU; Aşagidag A; Yaman S
J Ocul Pharmacol Ther; 2005 Feb; 21(1):68-74. PubMed ID: 15718830
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
Martínez A; Sánchez M
Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
[TBL] [Abstract][Full Text] [Related]
16. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
[TBL] [Abstract][Full Text] [Related]
17. Topiramate-induced bilateral angle-closure glaucoma.
Levy J; Yagev R; Petrova A; Lifshitz T
Can J Ophthalmol; 2006 Apr; 41(2):221-5. PubMed ID: 16767213
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
Ozturk F; Ermis SS; Inan UU
Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
[TBL] [Abstract][Full Text] [Related]
20. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
